Keywords: Ipsen Inspiration Biopharma, Hemophilia assets, Chapter 11 protection
Ipsen's hemophilia partner Inspiration Biopharma seeks Chapter 11 protection
Article | 01 November 2012
French drugmaker Ipsen (Euronext: IPN) announced yesterday that its partner, privately-held US firm Inspiration Biopharmaceuticals, is seeking Chapter 11 protection of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
